$VYX

Despite Fast-paced Momentum, NCR Voyix (VYX) Is Still a Bargain Stock

NCR Voyix (VYX) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.

Original reporting
Zacks Commentary · Zacks Equity Research
Published Jun 18, 2025, 12:50 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 19, 2025, 12:32 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Despite Fast-paced Momentum, NCR Voyix (VYX) Is Still a Bargain Stock — source image
Decision brief

The 30-second read

$VYXBullishMed
01

Why it matters

The positive momentum and valuation suggest a potential short-term trading opportunity, but risks remain due to market volatility and sector dynamics.

02

Market read

The news indicates a favorable short-term trading setup for VYX within the financial markets sector, with moderate global relevance.

03

What to watch

Potential upcoming earnings volatility or macroeconomic shifts could negatively impact VYX, which are not addressed in the article.

Timing: short-term (next 1-3 months)

Background

NCR Voyix (VYX) has shown recent strong price gains and is trading at a valuation considered attractive by some analysts.

Company-level read

Ticker impact

$VYXBullishMedium confidence
Context

The article highlights NCR Voyix (VYX) as a stock with recent strong momentum and attractive valuation, suggesting potential trading opportunities.

Expected impact

Moderate upward price movement expected over the next 1-3 months.

Evidence & confidence

The stock's momentum and valuation metrics support a positive outlook, but limited information on technical indicators and broader market conditions introduces some uncertainty.

Market effects

The article suggests strength in the financial markets sector, possibly indicating sector-wide optimism.

Primarily relevant to US markets, with limited regional impact.

Moderate, as NCR Voyix operates in a global context but is primarily US-focused.

Counterpoint

The stock's recent momentum may be a short-term anomaly; valuation could be inflated if broader market conditions deteriorate.

Key entities

  • NCR Voyix

    A technology company operating in the financial services sector.

Related articles

$VYXMed

NCR Voyix Q2 Earnings Call Highlights

NCR Voyix (NYSE:VYX) reported Q2 progress on enterprise platform transformations, including a remote Voyix POS installation for a large European grocery retailer completed in about half the usual time. Retail signed 40+ customers; retail revenue fell 20% to $365M due to hardware transition, but adjusted EBITDA rose 20% to $97M. Restaurant revenue fell 23% to $158M. Non-GAAP EPS was $0.17. Full-year 2026 outlook maintained: revenue $2.188B-$2.303B, adj EBITDA $432M-$447M, EPS $0.89-$0.92.

$VYXMedAI 8/10

NCR Voyix: Q2 Earnings Snapshot

NCR Voyix (VYX) reported Q2 earnings of $2 million and a net loss of 1 cent per share. Adjusted earnings were 17 cents per share, and revenue was $523 million. The company expects full-year earnings of 89 to 92 cents per share and revenue of $2.19 billion to $2.3 billion.

$VYXMed

NCR Voyix Corp (VYX): Completion of Acquisition or Disposition of Assets

NCR Voyix Corp (VYX) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. EX-99.1 2 exhibit991-q22026earningsr.htm EX-99.1 Document NEWS RELEASE NCR Voyix Reports Second Quarter 2026 Results ATLANTA, August 5, 2026 - NCR Voyix Corporation (NYSE: VYX) (“NCR Voyix” or the “Company”), a platform-powered leader in unified commerce for shopping and dining,

$MDTMed

Jury Orders Medtronic to Pay $88 Million After Finding Surgeons Were Not Adequately Warned About a Hernia Mesh

A federal jury ordered Medtronic’s Covidien unit to pay $88 million to Larry and Tammy Patterson after finding surgeons were not adequately warned about risks of Covidien’s Symbotex hernia mesh. The Aug. 4 verdict followed a three-week trial in Massachusetts. Jurors awarded $77 million to Larry and $11 million for loss of consortium, with no punitive damages.

$LMTMedAI 8/10

What is Patriot missile system, why its supplies are down

The article explains the U.S.-made Patriot mobile air defense system and why interceptor missile supplies are down. It cites Raytheon and Lockheed for system details and notes CSIS estimates about 65% of U.S. interceptors were expended Feb to July, leaving under 850. It says the U.S. approved 5,250 interceptors for Gulf states and awarded Lockheed a contract up to $58.6B.

$ETNMed

Eaton Gains on $7-Million Contract

Eaton (NYSE:ETN) said the U.S. Air Force Research Laboratory awarded it a $7 million, 24-month contract to use quantum computing, machine learning, and advanced visualization to improve power grid resilience and protection. The work, with Infleqtion and Penn State, targets detection and response to multiple concurrent physical and cyber threats, addressing NERC N-2 contingency requirements.